Acetaminophen modulation of HYDROCODONE (cas 125-29-1) reward in rats
-
Add time:10/01/2019 Source:sciencedirect.com
Abuse of prescription opioid analgesics in non-medical context has been on the rise over the past decade. The most commonly abused analgesic in this drug class consists of a combined formulation of HYDROCODONE (cas 125-29-1) and acetaminophen. The present study was aimed to determine the rewarding effects of hydrocodone, acetaminophen, and their combination using the conditioned place preference (CPP) paradigm. Using a 6-day CPP paradigm, rats were paired with hydrocodone (0.5, 1.0 or 5.0 mg/kg) or acetaminophen (50, 100 or 300 mg/kg) to determine whether the drugs given alone would produce a CPP. Rats conditioned with the highest dose of hydrocodone exhibited place preference, whereas rats conditioned with acetaminophen did not demonstrate place preference. In a second experiment, varying doses of hydrocodone and acetaminophen were combined to determine whether acetaminophen would enhance hydrocodone reward. Acetaminophen (100 mg/kg) enhanced the rewarding effects of hydrocodone (1 mg/kg), although the effect was unique to this particular dose combination. Higher or lower doses of acetaminophen combined with hydrocodone did not alter hydrocodone CPP. The present findings suggest that acetaminophen has a limited potential of modulating the rewarding properties of hydrocodone in rats.
We also recommend Trading Suppliers and Manufacturers of HYDROCODONE (cas 125-29-1). Pls Click Website Link as below: cas 125-29-1 suppliers
Prev:HYDROCODONE (cas 125-29-1) in postoperative personalized pain management: Pro-drug or drug?
Next:Anomalous observations of HYDROCODONE (cas 125-29-1) in patients on oxycodone) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Pharmacology in Emergency MedicineDecreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of HYDROCODONE (cas 125-29-1)09/29/2019
- Anomalous observations of HYDROCODONE (cas 125-29-1) in patients on oxycodone09/28/2019
- HYDROCODONE (cas 125-29-1) in postoperative personalized pain management: Pro-drug or drug?09/27/2019
- Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of HYDROCODONE (cas 125-29-1) After Coadministration With a Single-entity, Once-daily, Extended-release HYDROCODONE (cas 125-29-1) Tablet09/26/2019
- Effects of ceftriaxone on HYDROCODONE (cas 125-29-1) seeking behavior and glial glutamate transporters in P rats09/25/2019
- Selected Topics: ToxicologyComparison of Unintentional Exposures to Codeine and HYDROCODONE (cas 125-29-1) Reported to Texas Poison Centers09/24/2019
- Postoperative opioid prescribing practices and the impact of the HYDROCODONE (cas 125-29-1) schedule change09/10/2019
- Short CommunicationPharmacokinetics of HYDROCODONE (cas 125-29-1) and hydromorphone after oral HYDROCODONE (cas 125-29-1) in healthy Greyhound dogs09/09/2019
- Research reportReversal of oxycodone and HYDROCODONE (cas 125-29-1) tolerance by diazepam09/08/2019